“Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates As Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy”. Pakistan Journal of Medical & Cardiological Review 5, no. 2 (April 30, 2026): 1174–1180. Accessed April 30, 2026. https://pakjmcr.com/index.php/1/article/view/903.